Active

Third Rock Ventures

Investor type

VC

Founded

2007

AUM

$2 400 M

Location

Boston, Massachusetts, United States

Investment Ticket

$10-50 m

Investment Stage

Pre-seed Seed Series A Late Stage (Series C+)

Region of investment

North America
Investor profile last updated: 31 August, 2026

Profile

Third Rock Ventures is a prominent venture capital firm established in 2007, focused on discovering and building innovative life science companies. Headquartered in Boston, with an office in San Francisco, the firm has raised over $3.8 billion across multiple funds and invested in more than 60 portfolio companies. Their investments have led to the development of 18 to 23 market-approved products in various therapeutic areas, including cancer, cardiovascular disease, and mental health.

The firm specializes in biotechnology, diagnostics, medical devices, and pharmaceuticals, investing from pre-seed to Series D stages. Their strategic approach includes four key stages: Discover, Launch, Build, and Transform, which leverage their expertise in science and business to address unmet medical needs. Third Rock's leadership team, comprised of industry veterans, is dedicated to partnering with entrepreneurs and stakeholders to create sustainable companies that positively impact patient care.

Industry

HealthTech Software Media and Entertainment Marketing and Advertising Healthcare Services Fintech Financial Services Biotechnology Medical Devices Pharmaceuticals Life Sciences

Third Rock Ventures Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Third Rock Ventures II, L.P.
Venture Capital (VC)
Financial Services
Fintech
Healthcare Services
Marketing and Advertising
Media and Entertainment
HealthTech
Pre-seed
Seed
North America
$5-10 m
$426 M
September 2010
Third Rock Ventures III
Venture Capital (VC)
Healthcare Services
Life Sciences
HealthTech
Pre-seed
Seed
North America
$5-10 m
$516 M
March 2013
Third Rock Ventures IV, L.P.
Venture Capital (VC)
Healthcare Services
Life Sciences
HealthTech
Pre-seed
Seed
North America
$5-10 m
$616 M
October 2016
Third Rock Ventures V
Venture Capital (VC)
Healthcare Services
Life Sciences
HealthTech
Pre-seed
Seed
North America
$5-10 m
$770 M
June 2019
Third Rock Ventures Fund VI
Venture Capital (VC)
Healthcare Services
Life Sciences
HealthTech
Pre-seed
Seed
North America
$5-10 m
$1100 M
June 2022
Third Rock Ventures VII
Venture Capital (VC)
Healthcare Services
Life Sciences
HealthTech
Pre-seed
Seed
North America
$5-10 m
—
June 2026

Contacts

Name
Title
Email
avatar
Mark Levin partner
partner
m•••@•••
avatar
Jeb Keiper Venture Partner
Venture Partner
j•••@•••
Upgrade to see contacts
avatar
iUtKEgdWXP6mbAJ5 iUtKEgdWXP6mbAJ5
iUtKEgdWXP6mbAJ5
avatar
iUtKEgdWXP6mbAJ5 iUtKEgdWXP6mbAJ5
iUtKEgdWXP6mbAJ5
avatar
iUtKEgdWXP6mbAJ5 iUtKEgdWXP6mbAJ5
iUtKEgdWXP6mbAJ5
Investment-team contacts for Third Rock Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Third Rock Ventures

Third Rock Ventures is a venture capital firm. It backs companies at Pre-seed, Seed, Series A and Late Stage (Series C+), writing tickets of $10-50 m.
Third Rock Ventures is located in Boston, Massachusetts, United States.
Third Rock Ventures was founded in 2007.
Third Rock Ventures invests in companies and startups in HealthTech, Software, Media and Entertainment, Marketing and Advertising, Healthcare Services, Fintech, Financial Services, Biotechnology, Medical Devices, Pharmaceuticals, Life Sciences.
Third Rock Ventures invests in companies and startups in North America.
Third Rock Ventures invests in companies and startups at Pre-seed, Seed, Series A, Late Stage (Series C+).
Third Rock Ventures usually invests $10-50 m on average.
Third Rock Ventures has around $2 400m assets under management.
Third Rock Ventures last fund was created/launched in 2026-06-03
Third Rock Ventures can be reached through its website thirdrockventures.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Third Rock Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Third Rock Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 31 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.